Literature DB >> 9406530

Effects of ligand heterogeneity in the characterization of affinity columns by frontal analysis.

S A Tweed1, B Loun, D S Hage.   

Abstract

This study examined how the binding capacities and equilibrium constants measured by frontal analysis are affected by ligand heterogeneity in affinity columns. Equations derived for n- and two-site systems gave good agreement with results obtained for the binding of L-thyroxine to a column containing human serum albumin (HSA) and for the binding of (R)-warfarin to coupled columns containing HSA or pigeon serum albumin. The same equations were used to examine how different degrees of ligand heterogeneity affected the apparent binding capacities or equilibrium constants measured using the linear range of double-reciprocal frontal analysis plots. A large proportion of two-site systems gave good estimates (i.e., less than 10-20% error) for the true total column capacity and for the association constant of the highest affinity ligand in the column. A smaller, but still appreciable, fraction of all three- and four-site cases also produced good estimates of these values. The results of this work are not limited to protein-based affinity columns but should be applicable to any type of stationary phase that has well-defined binding regions and relatively fast, reversible interactions with solutes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9406530     DOI: 10.1021/ac970565m

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  27 in total

1.  Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography.

Authors:  K S Joseph; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-06-01       Impact factor: 3.205

Review 2.  Pharmaceutical and biomedical applications of affinity chromatography: recent trends and developments.

Authors:  David S Hage; Jeanethe A Anguizola; Cong Bi; Rong Li; Ryan Matsuda; Efthimia Papastavros; Erika Pfaunmiller; John Vargas; Xiwei Zheng
Journal:  J Pharm Biomed Anal       Date:  2012-01-14       Impact factor: 3.935

3.  Detection of heterogeneous drug-protein binding by frontal analysis and high-performance affinity chromatography.

Authors:  Zenghan Tong; K S Joseph; David S Hage
Journal:  J Chromatogr A       Date:  2011-05-06       Impact factor: 4.759

4.  Analysis of drug-protein binding using on-line immunoextraction and high-performance affinity microcolumns: Studies with normal and glycated human serum albumin.

Authors:  Ryan Matsuda; Donald Jobe; Jared Beyersdorf; David S Hage
Journal:  J Chromatogr A       Date:  2015-09-09       Impact factor: 4.759

5.  Analysis of drug interactions with modified proteins by high-performance affinity chromatography: binding of glibenclamide to normal and glycated human serum albumin.

Authors:  Ryan Matsuda; Jeanethe Anguizola; K S Joseph; David S Hage
Journal:  J Chromatogr A       Date:  2012-10-08       Impact factor: 4.759

6.  Studies of verapamil binding to human serum albumin by high-performance affinity chromatography.

Authors:  Rangan Mallik; Michelle J Yoo; Sike Chen; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-10-21       Impact factor: 3.205

7.  Analysis of drug interactions with high-density lipoprotein by high-performance affinity chromatography.

Authors:  Sike Chen; Matthew R Sobansky; David S Hage
Journal:  Anal Biochem       Date:  2009-10-13       Impact factor: 3.365

Review 8.  Analysis of biomolecular interactions using affinity microcolumns: a review.

Authors:  Xiwei Zheng; Zhao Li; Sandya Beeram; Maria Podariu; Ryan Matsuda; Erika L Pfaunmiller; Christopher J White; NaTasha Carter; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-01-27       Impact factor: 3.205

Review 9.  Characterization of drug-protein interactions in blood using high-performance affinity chromatography.

Authors:  David S Hage; Abby Jackson; Matthew R Sobansky; John E Schiel; Michelle J Yoo; K S Joseph
Journal:  J Sep Sci       Date:  2009-03       Impact factor: 3.645

10.  Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: characterization by high-performance affinity chromatography.

Authors:  K S Joseph; Annette C Moser; Sara B G Basiaga; John E Schiel; David S Hage
Journal:  J Chromatogr A       Date:  2008-10-01       Impact factor: 4.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.